Safety and efficacy of HAIC or lenvatinib combined with sintilimab as neoadjuvant therapy for high recurrence risk resectable stage IB solitary hepatocellular carcinoma: A prospective, randomized, two-cohort, exploratory phase II clinical study.
Year: 2025
Type: conference-abstract
Study design: Clinical Trial
Source: Journal of Clinical Oncology
Authors: Yunlong Cui, Chen Liu, Qiang Wu, Han Mu, Ge Yu, Dongming Liu, Xu Bao, Feng Fang, Wei Zhang, Huikai Li, Ping Chen, Hongyuan Zhou, Xiaomeng Liu, Lu Chen, Tianqiang Song
Language: English
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4410813530